ã€ã«ãããã£(ãã£ãŒãã¹ããŒã)éç¯çœª ãŠã€ã«ã¹ãã³ãããã¯
ãŠã€ã«ã¹ãã³ãããã¯ã¯ãã¢ãã¬ãã¯ãã ã飲ã¿ââãé£ã¹ãæªéåŽæè ã€ã«ãããã£(DS)ã®ç§å¯èšç»ã§ã
ã€ã«ãããã£(DS)ã®äººå£åæžèšç»ã¢ã³ã°ããµã¯ãœã³ããã·ã§ã³å®è¡äž
æŠåŸãã€ã«ãããã£(DS)ã«ããåšæ¥ã䜿ãæ¥æ¬ãæ¯é ããŠãã
åšæ¥ââãã¡ãã£ã¢ã¯ã€ã«ãããã£(DS)ã®èšããªããªã®ã§
ç¹äŸæ¿èªãããå®éšã§ãã¹ãŠã®åç©ãæ»äº¡ããã人éã§ã®æ²»éšäžã®ãã¯ã¯ãã³ãããããŠ
ãŠã€ã«ã¹ãã³ãããã¯ãåºã人å£åæžãæäŒã£ãŠãã
ã€ã«ãããã£(DS)ã®æªéã®ä»²éã®FDAã¯ãå±éºãªã¯ã¯ãã³ãšç¥ããªãããç¹äŸæ¿èªãããŠäººå£åæžãæäŒã£ãŠãã
FDA COVIDã¯ã¯ãã³ãã¡ã€ã« COVID-19ã®ã¢ãã¿ãªã³ã°ã®ããã®CBERèšç» ã¯ã¯ãã³ã®å®å šæ§ãšæå¹æ§
ttps://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2020-10/COVID-Anderso
n-508.pdf
FDA COVIDã¯ã¯ãã³ãã¡ã€ã«ã®16ããŒãžã翻蚳ãã
COVID-19ã¯ã¯ãã³ã®FDAå®å šç£èŠ èµ·ããããæ害äºè±¡ã®çµæã®ã¯ãŒãã³ã°ãªã¹ã
ã®ã©ã³ãã¬ãŒçå矀 æ¥æ§æ£åšæ§è³èé«ç 暪ææ§èé«ç è³ç èé«ç è³èé«ç é«èè³ç é«èç
çæ£çºäœ ã¹ãããŒã¯ ãã«ã³ã¬ãã·ãŒãšè±åçºäœ ã¢ããã£ã©ãã·ãŒ
æ¥æ§å¿çæ¢å¡ å¿çç å¿èç èªå·±å ç«çŸæ£ æ»äº¡ åŠåš ãšåºç£ã®çµæã»ã»ã» ãã®ä»ã®æ¥æ§è±é«æ§çŸæ£
éã¢ããã£ã©ãã·ãŒã¢ã¬ã«ã®ãŒåå¿ è¡å°æ¿æžå°ç æçš®æ§è¡ç®¡å ååºçå矀 éèè¡æ å¡æ ç
é¢ç¯çããã³é¢ç¯ç é¢ç¯ç å·åŽç å°å ã®å€ç³»çµ±ççæ§çå矀 ã¯ã¯ãã³åŒ·åçŸæ£
âãããªå±éºãªçç¶ãåºããã¯ã¯ãã³ããããã奎ã¯ãã€ã«ãããã£(DS)ã®èšããªãã®ç¯çœªè ã§ã
æ²»éšäžã®ç¹äŸæ¿èªããå±éºãªã¯ã¯ãã³ã¯ãSARS-COV-2ã«ã¯å¹ããªãâã§ã
ãŠã€ã«ã¹ãã³ãããã¯ã¯ãã¢ãã¬ãã¯ãã ã飲ã¿ââãé£ã¹ãæªéåŽæè ã€ã«ãããã£(DS)ã®ç§å¯èšç»ã§ã
ã€ã«ãããã£(DS)ã®äººå£åæžèšç»ã¢ã³ã°ããµã¯ãœã³ããã·ã§ã³å®è¡äž
æŠåŸãã€ã«ãããã£(DS)ã«ããåšæ¥ã䜿ãæ¥æ¬ãæ¯é ããŠãã
åšæ¥ââãã¡ãã£ã¢ã¯ã€ã«ãããã£(DS)ã®èšããªããªã®ã§
ç¹äŸæ¿èªãããå®éšã§ãã¹ãŠã®åç©ãæ»äº¡ããã人éã§ã®æ²»éšäžã®ãã¯ã¯ãã³ãããããŠ
ãŠã€ã«ã¹ãã³ãããã¯ãåºã人å£åæžãæäŒã£ãŠãã
ã€ã«ãããã£(DS)ã®æªéã®ä»²éã®FDAã¯ãå±éºãªã¯ã¯ãã³ãšç¥ããªãããç¹äŸæ¿èªãããŠäººå£åæžãæäŒã£ãŠãã
FDA COVIDã¯ã¯ãã³ãã¡ã€ã« COVID-19ã®ã¢ãã¿ãªã³ã°ã®ããã®CBERèšç» ã¯ã¯ãã³ã®å®å šæ§ãšæå¹æ§
ttps://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2020-10/COVID-Anderso
n-508.pdf
FDA COVIDã¯ã¯ãã³ãã¡ã€ã«ã®16ããŒãžã翻蚳ãã
COVID-19ã¯ã¯ãã³ã®FDAå®å šç£èŠ èµ·ããããæ害äºè±¡ã®çµæã®ã¯ãŒãã³ã°ãªã¹ã
ã®ã©ã³ãã¬ãŒçå矀 æ¥æ§æ£åšæ§è³èé«ç 暪ææ§èé«ç è³ç èé«ç è³èé«ç é«èè³ç é«èç
çæ£çºäœ ã¹ãããŒã¯ ãã«ã³ã¬ãã·ãŒãšè±åçºäœ ã¢ããã£ã©ãã·ãŒ
æ¥æ§å¿çæ¢å¡ å¿çç å¿èç èªå·±å ç«çŸæ£ æ»äº¡ åŠåš ãšåºç£ã®çµæã»ã»ã» ãã®ä»ã®æ¥æ§è±é«æ§çŸæ£
éã¢ããã£ã©ãã·ãŒã¢ã¬ã«ã®ãŒåå¿ è¡å°æ¿æžå°ç æçš®æ§è¡ç®¡å ååºçå矀 éèè¡æ å¡æ ç
é¢ç¯çããã³é¢ç¯ç é¢ç¯ç å·åŽç å°å ã®å€ç³»çµ±ççæ§çå矀 ã¯ã¯ãã³åŒ·åçŸæ£
âãããªå±éºãªçç¶ãåºããã¯ã¯ãã³ããããã奎ã¯ãã€ã«ãããã£(DS)ã®èšããªãã®ç¯çœªè ã§ã
æ²»éšäžã®ç¹äŸæ¿èªããå±éºãªã¯ã¯ãã³ã¯ãSARS-COV-2ã«ã¯å¹ããªãâã§ã